EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of COVID-19 on the treatment outcomes of secretory otitis media

Jishuai Zhang, Weihao Zhao, Ting Zhang, Qiying Wu, Jing Di, Xiaobo Mao

The Journal of Infection in Developing Countries · 31.03.2026 · 20 (03) · 327-331

DOI: 10.3855/jidc.21341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.03.2026. Verfasst von Jishuai Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery of the 928th Hospital of the Joint Logistics Support Force, Haikou, China. Hauptthemen laut MEDLINE: COVID-19, Otitis Media with Effusion. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The World Health Organization (WHO) officially lifted the global emergency designation for coronavirus disease 2019 (COVID-19) in May 2023. Nonetheless, the long-term repercussions of the pandemic—referred to as ‘long COVID’—have persisted. It is also highly likely for the disease to be complicated by secretory otitis media (SOM). This study aimed to determine if there is anything particularly distinctive about SOM associated with long-COVID, and could it affect the therapeutic outcomes of the latter. Methodology: A total of 102 patients diagnosed with COVID-19-associated SOM between December 2022 and May 2023 were retrospectively analyzed. Pre- and post-treatment pure-tone audiometry thresholds were assessed to evaluate therapeutic efficacy. Follow-up assessments were performed at 1, 3, 6, and 12 months’ post treatment, and the findings were compared with those of a control group of 98 patients who had SOM but not COVID-19 infection during the same time frame.

Results

All patients showed normal hearing thresholds post treatment. A comparative analysis using a two-sample t-test revealed no statistically significant difference in the average speech-hearing thresholds between the two groups post-treatment (t = 0.099, p = 0.92). No recurrence was observed in either group during the year-long follow-up period.

Conclusions

Although COVID-19 is commonly associated with SOM, patients can expect satisfactory recovery of their hearing function with proactive treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Otitis Media with EffusionHumansFemaleTreatment OutcomeRetrospective StudiesMaleMiddle AgedAudiometry, Pure-ToneAdultSARS-CoV-2Post-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

COVID-19SOMdeafnesssecretory otitis media

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery of the 928th Hospital of the Joint Logistics Support Force, Haikou, China.
  • Department of Otolaryngology Head and Neck Surgery, General Hospital of Tibet Military Region of PLA, Lhasa, China.

Zitieren

APA

Zhang, J., Zhao, W., Zhang, T., Wu, Q., Di, J., & Mao, X. (2026). Impact of COVID-19 on the treatment outcomes of secretory otitis media. The Journal of Infection in Developing Countries, 20(03), 327-331. https://doi.org/10.3855/jidc.21341

Vancouver

Zhang J, Zhao W, Zhang T, Wu Q, Di J, Mao X. Impact of COVID-19 on the treatment outcomes of secretory otitis media. The Journal of Infection in Developing Countries. 2026;20(03):327-331. doi:10.3855/jidc.21341

BibTeX
@article{Zhang2026,
  author = {Zhang, Jishuai and Zhao, Weihao and Zhang, Ting and Wu, Qiying and Di, Jing and Mao, Xiaobo},
  title = {Impact of COVID-19 on the treatment outcomes of secretory otitis media},
  journal = {The Journal of Infection in Developing Countries},
  year = {2026},
  volume = {20},
  number = {03},
  pages = {327--331},
  doi = {10.3855/jidc.21341}
}
Kostenlos starten →